Source: The Lakeside, OR weather data displayed above is derived from the NOAA (National Oceanic and Atmospheric). Air quality and pollution data is derived from the EPA (United States Environmental Protection Agency).
DUBLIN, June 15, 2016 /PRNewswire/ -- Allergan plc (NYSE: AGN) announced today that the 510(k) Premarket Notification Application for the XEN Glaucoma Treatment System (consisting of the XEN45 Gel Stent and the XEN Injector) has been accepted for filing by the U.S. Food and Drug Administration (FDA).
Valbenazine isnât the first-ever VMAT2 inhibitor to be approved by the FDA, itâs just the first-ever VMAT2 inhibitor approved for the treatment of TD. Tetrabenazine (trade name XenazineÂ®) and deutetrabenazine (trade name AustedoÂ®) are two other VMAT2 inhibitors already approved by the FDA for Huntingtonâs disease (a genetic disorder that, like TD, also includes choreiform movements).